NO20084002L - Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det samme - Google Patents
Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det sammeInfo
- Publication number
- NO20084002L NO20084002L NO20084002A NO20084002A NO20084002L NO 20084002 L NO20084002 L NO 20084002L NO 20084002 A NO20084002 A NO 20084002A NO 20084002 A NO20084002 A NO 20084002A NO 20084002 L NO20084002 L NO 20084002L
- Authority
- NO
- Norway
- Prior art keywords
- peg
- denotes
- residue
- well
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Peptider og peptidderivater ifølge formel I: H2N-GHRPXIX2X3X4X5X6X7X8PX9X10X11PX12PPPX13X14X15X16GYR-X17 (I), hvori: Xl - X16 representerer en av de 20 genetisk kodede aminosyrer, X17 representerer OR1, hvor R1 = hydrogen eller (C1 - C10 - alkyl), eller NR2R3, R2 og R3 er identisk eller forskjellig og representerer hydrogen, (C1 - C10 - alkyl), eller en rest -PEG5-60K, hvori PEG-resten er linket til N-atomet via et avstandsstykke, eller en rest NH-Y-Z-PEG5-60K, hvori Y representerer en kjemisk binding eller en genetisk kodet aminosyre blant gruppen av S, C, K eller R, og Z representerer et avstandsstykke hvor en polyetylenglykol (PEG)-rest kan være linket, så vel som fysiologisk akseptable salter derav, eller hvori: X15 eller X16 representerer en aminosyre fra gruppen av C eller K, som er linket til en rest Z-PEG5-60K via heteroatomet i sidekjeden, og hvori X17 representerer OR1, hvor R1 = hydrogen eller (C1 - C10 - alkyl), eller NR2R3, R2 og R3 er identisk eller forskjellig og representerer hydrogen eller (C1 - C10 - alkyl), så vel som fysiologisk akseptable salter derav.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT3012006 | 2006-02-23 | ||
| PCT/AT2007/000095 WO2007095660A1 (en) | 2006-02-23 | 2007-02-23 | Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20084002L true NO20084002L (no) | 2008-11-18 |
Family
ID=38042580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20084002A NO20084002L (no) | 2006-02-23 | 2008-09-19 | Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det samme |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20110098442A1 (no) |
| EP (2) | EP1987062B1 (no) |
| JP (1) | JP2009527502A (no) |
| KR (1) | KR20090005300A (no) |
| CN (1) | CN101389653A (no) |
| AT (1) | ATE513853T1 (no) |
| AU (1) | AU2007219031B2 (no) |
| CA (1) | CA2641908A1 (no) |
| ES (1) | ES2371038T3 (no) |
| IL (1) | IL193435A0 (no) |
| MX (1) | MX2008010930A (no) |
| NO (1) | NO20084002L (no) |
| RU (1) | RU2008137796A (no) |
| WO (1) | WO2007095660A1 (no) |
| ZA (1) | ZA200807028B (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005256121B2 (en) * | 2004-06-25 | 2011-03-03 | Fibrex Medical Research & Development Gmbh | Use of peptides derived from the A alpha or B beta chain of human fibrinogen for the treatment of shock |
| US8722623B2 (en) * | 2007-09-17 | 2014-05-13 | University Of Maryland, Baltimore | Compositions and methods utilizing fibrin beta chain fragments |
| JP5410997B2 (ja) * | 2008-01-31 | 2014-02-05 | 則行 川村 | うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断 |
| US20090286740A1 (en) * | 2008-05-15 | 2009-11-19 | Fibrex Medical Research & Development Gmbh | Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| US20090286725A1 (en) * | 2008-05-15 | 2009-11-19 | Fibrex Medical Research & Development Gmbh | Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| US7884074B2 (en) * | 2008-05-15 | 2011-02-08 | Ikaria Development Subsidiary Two, LLC | Compounds and methods for prevention and/or treatment of inflammation using the same |
| US8088890B2 (en) * | 2008-09-26 | 2012-01-03 | Fibrex Medical Research & Development Gmbh | Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| WO2010043444A2 (en) * | 2008-10-15 | 2010-04-22 | Fibrex Medical Research & Development Gmbh | Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof |
| US20100152832A1 (en) * | 2008-12-12 | 2010-06-17 | Medtronic Vascular, Inc. | Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta |
| WO2010118309A2 (en) * | 2009-04-10 | 2010-10-14 | Board Of Regents, The University Of Texas System | Inhibitors of stat3 and uses thereof |
| WO2017210539A1 (en) | 2016-06-02 | 2017-12-07 | University Of Maryland, Baltimore | Compositions for inhibiting fibrin-vldl receptor-dependent inflammation and methods of treatment |
| WO2019011879A1 (en) | 2017-07-09 | 2019-01-17 | Rainer Henning | THERAPEUTIC AGENT FOR THE TREATMENT OF CAPILLARY LEAK SYNDROME |
| JP7429032B2 (ja) * | 2019-12-24 | 2024-02-07 | 学校法人順天堂 | 間質性肺炎モデル非ヒト動物の作製方法 |
| EP3912679A1 (en) | 2020-05-19 | 2021-11-24 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Bbeta-15-42 for the treatment of viral endothelitis |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966848A (en) * | 1988-02-08 | 1990-10-30 | The General Hospital Corporation | Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase |
| US5223421A (en) * | 1989-10-25 | 1993-06-29 | The General Hospital Corporation | Identification of methionine Nα-acetyltransferase |
| US5965107A (en) * | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
| DE69233069T2 (de) * | 1991-03-15 | 2003-11-27 | Amgen Inc., Thousand Oaks | Pegylation von polypeptiden |
| US5688489A (en) * | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| US6323311B1 (en) * | 1999-09-22 | 2001-11-27 | University Of Utah Research Foundation | Synthesis of insulin derivatives |
| BR0116122A (pt) * | 2000-12-12 | 2003-10-14 | Fibrex Medical Res & Dev Gmbh | Peptìdeos e/ou proteìnas bem como seu uso para preparar uma composição farmacêutica, terapêutica e/ou preventiva |
| DE10314329A1 (de) * | 2003-03-28 | 2004-10-21 | Zf Friedrichshafen Ag | Antriebsstrang zum Antrieb eines Mobil-Fahrzeugs |
| WO2004101600A2 (en) | 2003-05-12 | 2004-11-25 | Affymax, Inc. | Novel poly(ethylene glycol) modified compounds and uses thereof |
| AU2005256121B2 (en) * | 2004-06-25 | 2011-03-03 | Fibrex Medical Research & Development Gmbh | Use of peptides derived from the A alpha or B beta chain of human fibrinogen for the treatment of shock |
| AT502987A1 (de) * | 2005-12-23 | 2007-07-15 | Fibrex Medical Res & Dev Gmbh | Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen |
-
2007
- 2007-02-23 EP EP07701338A patent/EP1987062B1/en not_active Not-in-force
- 2007-02-23 CA CA002641908A patent/CA2641908A1/en not_active Abandoned
- 2007-02-23 AU AU2007219031A patent/AU2007219031B2/en not_active Ceased
- 2007-02-23 EP EP10009684A patent/EP2256131A1/en not_active Withdrawn
- 2007-02-23 WO PCT/AT2007/000095 patent/WO2007095660A1/en not_active Ceased
- 2007-02-23 US US12/280,543 patent/US20110098442A1/en not_active Abandoned
- 2007-02-23 RU RU2008137796/04A patent/RU2008137796A/ru not_active Application Discontinuation
- 2007-02-23 CN CNA2007800063032A patent/CN101389653A/zh active Pending
- 2007-02-23 KR KR1020087023213A patent/KR20090005300A/ko not_active Withdrawn
- 2007-02-23 ES ES07701338T patent/ES2371038T3/es active Active
- 2007-02-23 AT AT07701338T patent/ATE513853T1/de active
- 2007-02-23 MX MX2008010930A patent/MX2008010930A/es unknown
- 2007-02-23 US US11/678,535 patent/US7799758B2/en not_active Expired - Fee Related
- 2007-02-23 ZA ZA200807028A patent/ZA200807028B/xx unknown
- 2007-02-23 JP JP2008555560A patent/JP2009527502A/ja active Pending
-
2008
- 2008-08-13 IL IL193435A patent/IL193435A0/en unknown
- 2008-09-19 NO NO20084002A patent/NO20084002L/no not_active Application Discontinuation
-
2010
- 2010-06-22 US US12/820,804 patent/US20100279924A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2641908A1 (en) | 2007-08-30 |
| IL193435A0 (en) | 2011-08-01 |
| ZA200807028B (en) | 2009-11-25 |
| EP1987062B1 (en) | 2011-06-22 |
| AU2007219031B2 (en) | 2011-11-03 |
| JP2009527502A (ja) | 2009-07-30 |
| EP2256131A1 (en) | 2010-12-01 |
| US20100279924A1 (en) | 2010-11-04 |
| US7799758B2 (en) | 2010-09-21 |
| CN101389653A (zh) | 2009-03-18 |
| ES2371038T3 (es) | 2011-12-26 |
| WO2007095660A1 (en) | 2007-08-30 |
| EP1987062A1 (en) | 2008-11-05 |
| KR20090005300A (ko) | 2009-01-13 |
| AU2007219031A1 (en) | 2007-08-30 |
| US20110098442A1 (en) | 2011-04-28 |
| RU2008137796A (ru) | 2010-03-27 |
| MX2008010930A (es) | 2008-10-29 |
| US20080039388A1 (en) | 2008-02-14 |
| ATE513853T1 (de) | 2011-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20084002L (no) | Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det samme | |
| NO20092774L (no) | HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette | |
| CY1109722T1 (el) | Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole | |
| BRPI0413276B8 (pt) | derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica | |
| DK1877435T3 (da) | Glucagon-lignende peptid 2 (GLP-2)-analoger | |
| AR109135A2 (es) | Forma sólida de una sal hidratada de tartrato de un compuesto de pirrolidina inhibidor de dpp-iv | |
| PE20140974A1 (es) | Compuestos de insulina lispro pegilada | |
| CY1113299T1 (el) | Πολυπεπτιδια απροτινινης για τη μεταφορα μιας ενωσης μεσα στον αιματοεγκεφαλικο φραγμο | |
| NO20071369L (no) | Antimikrobiske peptider omfattende et arginin- og/eller lysin-inneholdende motiv | |
| MX2011011130A (es) | Proteina o peptido de fusion con vida media in vivo incrementada mantenido por liberacion in vivo sostenida, y metodo para incrementar la vida media in vivo usando el mismo. | |
| ATE357455T1 (de) | Neue effektoren der dipeptidyl peptidase iv zur topischen anwendung | |
| DE602005008996D1 (de) | Radiofluorierte peptide | |
| NO20075927L (no) | IL-21 varianter | |
| JP2009527503A5 (no) | ||
| EP2275439A3 (en) | Novel insulin derivatives | |
| BRPI0718996B8 (pt) | método para a preparação de um peptídio da fórmula h-d-?-nal-[cys-tyr-d-trp-lys-val-cys]-thr-nh2 ou h-d-?-nal-cys(acm)-tyr-d-trp-lys-val-cys(acm)-thr | |
| DK1755634T3 (da) | Oligopeptider til formindskelse af forhöjet blodurinstofkoncentration | |
| ATE517118T1 (de) | Bis-met-histone | |
| MX2010012042A (es) | Peptidos, peptidomimeticos y derivados de los mismos, su fabricacion asi como su uso para preparar una composicion farmaceutica terapeutica y/o preventivamente activa. | |
| AR059300A1 (es) | Peptidos inhibidores de la fusion de vih con propiedades biologicas mejoradas | |
| NO20076448L (no) | Novel piperidine carboxylic acid amide derivatives | |
| ATE443722T1 (de) | Peptide und peptidderivate, ihre herstellung sowie ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung | |
| WO2010028066A3 (en) | Cd133 epitopes | |
| MX349364B (es) | Variante de alfa-1 antitripsina novedosa, método de preparación de la misma, y uso de la misma. | |
| ATE464058T1 (de) | Orale zusammensetzung aus naturstoffen zum erhalt der richtigen hautfeuchtigkeit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |